×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Nagendran Sukumar

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
TSHATaysha Gene Therapies, Inc.Nagendran SukumarPresident and Head of R&DMay 16, 2023Buy$0.685,0003,40034,226May 18, 2023, 04:44 PM
TSHATaysha Gene Therapies, Inc.Nagendran SukumarDirectorFeb 02, 2022Buy$8.0110,00080,10029,226Feb 03, 2022, 09:21 AM
SLDBSolid Biosciences Inc.Nagendran SukumarDirectorJul 25, 2019Option Exercise$4.6532,258150,00034,258Jul 29, 2019, 04:30 PM
AVXSAveXis, Inc.Nagendran SukumarSr. VP & Chief Medical OfficerMar 01, 2018Sale$72.333,560257,4951,780Mar 05, 2018, 12:00 AM
AVXSAveXis, Inc.Nagendran SukumarSr. VP & Chief Medical OfficerFeb 01, 2018Sale$68.223,560242,8461,780Feb 05, 2018, 04:58 PM
AVXSAveXis, Inc.Nagendran SukumarSr. VP & Chief Medical OfficerJan 02, 2018Sale$64.103,560228,1851,780Jan 04, 2018, 05:38 PM
AVXSAveXis, Inc.Nagendran SukumarSr. VP & Chief Medical OfficerDec 01, 2017Sale$56.623,560201,5731,780Dec 05, 2017, 06:32 PM
AVXSAveXis, Inc.Nagendran SukumarSr. VP & Chief Medical OfficerNov 01, 2017Sale$59.873,560213,1211,780Nov 03, 2017, 05:01 PM
AVXSAveXis, Inc.Nagendran SukumarSr. VP & Chief Medical OfficerOct 02, 2017Sale$57.863,560205,9841,780Oct 03, 2017, 05:05 PM
AVXSAveXis, Inc.Nagendran SukumarSr. VP & Chief Medical OfficerSep 01, 2017Sale$55.863,560198,8551,780Sep 05, 2017, 05:22 PM
AVXSAveXis, Inc.Nagendran SukumarSr. VP & Chief Medical OfficerAug 01, 2017Sale$55.003,560195,7831,780Aug 03, 2017, 05:02 PM
AVXSAveXis, Inc.Nagendran SukumarSr. VP & Chief Medical OfficerJul 03, 2017Sale$50.183,560178,6241,780Jul 05, 2017, 06:05 PM
AVXSAveXis, Inc.Nagendran SukumarSr. VP & Chief Medical OfficerJun 01, 2017Option Exercise$44.693,560159,0911,780Jun 02, 2017, 04:33 PM
AVXSAveXis, Inc.Nagendran SukumarSr. VP & Chief Medical OfficerMay 01, 2017Sale$49.933,560177,7461,780May 02, 2017, 04:59 PM
AVXSAveXis, Inc.Nagendran SukumarSr. VP & Chief Medical OfficerApr 03, 2017Option Exercise$47.303,562168,4831,781Apr 05, 2017, 05:16 PM